2,597 results on '"Di Marzo, Vincenzo"'
Search Results
102. Goods and bads of endocannabinoid system as a therapeutic target: Lessons learned after 30 years
103. Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture
104. Trick or treat from food endocannabinoids?
105. New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno–modulatory activity
106. Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis
107. Protective Effect of Palmitoylethanolamide in a Rat Model of Cystitis
108. Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa
109. Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligands
110. Comparing transgenic production to supplementation of ω-3 PUFA reveals distinct but overlapping mechanisms underlying protection against metabolic and hepatic disorders
111. First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury
112. Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome
113. Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer’s disease
114. Impact of selenium on the intestinal microbiome-eCBome axis in the context of diet-related metabolic health in mice
115. Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families
116. TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β‐catenin signalling
117. The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity
118. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
119. Temperature-Sensitive Transient Receptor Potential Channels as Ionotropic Cannabinoid Receptors
120. Chapter 2.6 - Alterations of the endocannabinoid system by endocrine-disrupting chemicals: Effects on metabolism and reproduction
121. Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes
122. Hemp seed significantly modulates the endocannabinoidome and produces beneficial metabolic effects with improved intestinal barrier function and decreased inflammation in mice under a high-fat, high-sucrose diet as compared with linseed
123. Short-term supplementation with ω-3 polyunsaturated fatty acids modulates primarily mucolytic species from the gut luminal mucin niche in a human fermentation system
124. Cannabinoids and Chronic Liver Diseases
125. Endocannabinoid Modulation in the Olfactory Epithelium
126. Structure–affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist
127. 1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor
128. The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of K v 7 channels
129. Endocannabinoids in Energy Homeostasis and Metabolic Disorders
130. Techniques for the Cellular and Subcellular Localization of Endocannabinoid Receptors and Enzymes in the Mammalian Brain
131. Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy
132. Dose-Specific Effects of Di-Isononyl Phthalate on the Endocannabinoid System and on Liver of Female Zebrafish
133. Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy
134. CB1 receptor activation induces intracellular Ca2+ mobilization and 2-arachidonoylglycerol release in rodent spinal cord astrocytes
135. Endocannabinoids: A unique opportunity to develop multitarget analgesics
136. Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus
137. Sex-dependent effects of neonatal maternal deprivation on endocannabinoid levels in the adipose tissue: influence of diet
138. Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis
139. Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity
140. Potential use of cannabimimetics in the treatment of cancer
141. The Endocannabinoid System and its Modulation by Phytocannabinoids
142. Obesity: The Fat Tissue Disease Version of Cancer
143. Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1
144. Biaryl tetrazolyl ureas as inhibitors of endocannabinoid metabolism: Modulation at the N-portion and distal phenyl ring
145. The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
146. Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals
147. Neuromodulatory Actions of Endocannabinoids in Pain and Sedation
148. Cannabimimetic Eicosanoids in Cancer and Inflammation: an Update
149. Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons
150. Introduction: Endocannabinoids in nervous system health and disease: the big picture in a nutshell
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.